CD274 and neoplasm: According to our findings, major pathologic response and tumor PD-L1 expression were not significantly correlated (50% in patients with PD-L1 < 1%; 23.1% in patients with PD-L1 ≥ 1%; P = 0.221), which indicates that PD-L1 expression cannot predict treatment benefit.